In early-stage breast cancer, the estrogen receptor interacts with correlation between human epidermal growth factor receptor 2 status and age at diagnosis, tumor grade, and lymph node involvement

Patrick Neven, Olivier Brouckaert, Vanya Van Belle, Isabelle Vanden Bempt, Wouter R. Hendrickx, Hyonil Cho, Karen Deraedt, Ben Van Calster, Sabine Van Huffel, Philippe Moerman, Frederic Amant, Karin Leunen, Ann Smeets, Hans Wildiers, Robert Paridaens, Ignace Vergote, Marie Rose Christiaens

Research output: Contribution to journalLetter

6 Citations (Scopus)
Original languageEnglish
Pages (from-to)1768-1769
Number of pages2
JournalJournal of Clinical Oncology
Volume26
Issue number10
DOIs
Publication statusPublished - 15 Sep 2008
Externally publishedYes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Neven, P., Brouckaert, O., Van Belle, V., Vanden Bempt, I., Hendrickx, W. R., Cho, H., Deraedt, K., Van Calster, B., Van Huffel, S., Moerman, P., Amant, F., Leunen, K., Smeets, A., Wildiers, H., Paridaens, R., Vergote, I., & Christiaens, M. R. (2008). In early-stage breast cancer, the estrogen receptor interacts with correlation between human epidermal growth factor receptor 2 status and age at diagnosis, tumor grade, and lymph node involvement. Journal of Clinical Oncology, 26(10), 1768-1769. https://doi.org/10.1200/JCO.2007.15.6141